Vivos Therapeutics News

Vivos Therapeutics | 8-K: Current report

Nov 27 17:28 ET

Vivos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Huntsman Ronald Kirk

Nov 27 16:49 ET

Vivos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Amman Bradford K.

Nov 27 16:48 ET

Vivos Therapeutics | 8-K: Vivos Therapeutics Reports Third Quarter 2024 Financial Results and Provides Operational Update

Nov 14 17:00 ET

Vivos Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(4.99%),Steven Boyd(4.99%)

Nov 14 16:54 ET

Vivos Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 14 16:22 ET

Vivos Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Ionic Ventures, LLC(1.8%),Ionic Management, LLC(1.8%), etc.

Nov 14 16:14 ET

Vivos Therapeutics | DEFA14A: Others

Nov 6 16:20 ET

Vivos Therapeutics | DEF 14A: Definitive information statements

Oct 7 17:15 ET

Vivos Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Ionic Ventures, LLC(8.7%),Ionic Management, LLC(8.7%), etc.

Sep 24 15:02 ET

Vivos Therapeutics | 8-K: Current report

Sep 20 08:07 ET

Vivos Therapeutics | 424B5: Prospectus

Sep 20 08:02 ET

Vivos Therapeutics | 8-K: Current report

Sep 18 08:02 ET

Vivos Therapeutics | 8-K: Current report

Sep 17 16:11 ET

Vivos Therapeutics | 8-K: Current report

Sep 12 17:04 ET

Vivos Therapeutics | 8-K: Vivos Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update

Aug 15 12:57 ET

Vivos Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 14 16:28 ET

Vivos Therapeutics | 424B1: Prospectus

Aug 8 17:24 ET

Vivos Therapeutics | EFFECT: Others

Aug 8 06:11 ET

Vivos Therapeutics | CORRESP: CORRESP

Aug 5 13:00 ET